Dell Technologies (DELL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Urban Outfitters (URBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Burlington Stores (BURL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Winn-Dixie expands Amazon return kiosks to 68 additional stores across Florida.

Google's hotly anticipated Gemini 3 AI model is rolling out today. The company said the new model is both smarter and better for visual learning.

Maybe more than other model releases, this one seems to have the attention of Google's competitors. Will it put the company at the top of the A.I.

Microsoft's Agent 365 will be able to automatically pick up on artificial intelligence agents developed with the company's software, as well as systems from Adobe, ServiceNow and Workday. IT administrators will be able to use Agent 365 to approve new agents, see which ones are becoming popular and find out how many hours of employee time they're saving each week.

Google announced Gemini 3, an upgraded artificial intelligence model, almost eight months after the company rolled out Gemini 2.5. The company said its latest suite of AI models will require users to do "less prompting" to get the desired results.

TLX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Nov. 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA rejection letter. National shareholders rights firm Hagens Berman is actively investigating the alleged legal claims and urges Telix investors who suffered substantial losses to submit your losses now.

OSHKOSH, Wis.--(BUSINESS WIRE)---- $OSK #oshkoshcorporation--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles, equipment and services, will participate in a fireside chat at the UBS Global Industrials and Transportation Conference. Presenting on behalf of Oshkosh will be President and CEO, John Pfeifer. The event is scheduled to start at 2:40 p.m. EST on December 2, 2025. A live webcast of the presentation can be accessed via the company's website at www.oshkoshcorp.com. A replay of the webcas.

SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (NASDAQ:OKTA), the leading independent identity partner, today announced that it has been recognized as a Leader in the 2025 Gartner Magic Quadrant for Access Management for the ninth consecutive year. A complimentary version of the full report can be found here. Gartner defines access management (AM) as tools that include authentication, authorization, single sign-on (SSO), and adaptive access capabilities for modern standards-based web applications,.

SANTA ROSA, Calif.--(BUSINESS WIRE)--Compact, modular system with integrated multi-test capability and up to 20-core parallel testing for high-volume efficiency.

MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE:ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced plans to build a new greenfield manufacturing site in Southeastern Wisconsin. The project marks the next step in the company's previously announced $2 billion investment in plants, digital infrastructure, and talent to grow share, build resilience, and expand margins over the next five years. The facility has the potential t.

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York.

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Electronic Arts Inc. (NASDAQ: EA) today confirmed plans for the future of the EA SPORTS™ F1® game series, the official games of the FIA Formula One World Championship™. Since launch, EA SPORTS™ F1® 25 has received praise from players, media, content creators, F1 drivers and more. Now looking forward, players in F1 25 will be able to expand their experience next year with the full 2026 FIA Formula One World Championship™. Coming in 2026 as a paid expansion*.

The new model could help the company leverage its built-in advantages of scale and profitability—if it can meet users' expectations.

Embedded assistant revolutionizes how members navigate their health care journey WOONSOCKET, R.I. , Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience.

Charter Adopts GitLab Duo with Q Developer to Accelerate Innovation for Spectrum Customers STAMFORD, Conn. and NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR) today announced a strategic agreement with Amazon Web Services (AWS) that establishes AWS as one of Charter's strategic GenAI providers.

On Tuesday, Google released Gemini 3, its latest and most advanced foundation model, which is now immediately available through the Gemini app and AI search interface.

— Non-Cystic Fibrosis Bronchiectasis (NCFB) Is a Serious, Progressive Lung Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI Is a First-in-Disease, First-in-Class DPP1 Inhibitor Targeting Neutrophilic Inflammation — — BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J. , Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that the European Commission has approved BRINSUPRI (brensocatib 25 mg tablets) for the treatment …